Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.
2.

Best practices in diagnostic immunohistochemistry: myoepithelial markers in breast pathology.

Dewar R, Fadare O, Gilmore H, Gown AM.

Arch Pathol Lab Med. 2011 Apr;135(4):422-9. doi: 10.1043/2010-0336-CP.1. Review.

PMID:
21466356
3.

Detection of stromal invasion in breast cancer: the myoepithelial markers.

Yaziji H, Gown AM, Sneige N.

Adv Anat Pathol. 2000 Mar;7(2):100-9. Review.

PMID:
10721417
4.

Use of immunohistochemistry in the diagnosis of problematic breast lesions.

Lee AH.

J Clin Pathol. 2013 Jun;66(6):471-7. doi: 10.1136/jclinpath-2012-201109. Epub 2013 Mar 13. Review.

PMID:
23486609
5.

The usefulness of p63 as a marker of breast myoepithelial cells.

Batistatou A, Stefanou D, Arkoumani E, Agnantis NJ.

In Vivo. 2003 Nov-Dec;17(6):573-6. Review.

PMID:
14758723
6.
7.

Ductal carcinoma in situ of the breast: current concepts and future directions.

Siziopikou KP.

Arch Pathol Lab Med. 2013 Apr;137(4):462-6. doi: 10.5858/arpa.2012-0078-RA. Review.

PMID:
23544935
8.

Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression.

Barsky SH, Karlin NJ.

J Mammary Gland Biol Neoplasia. 2005 Jul;10(3):249-60. Review.

PMID:
16807804
9.

Use of Myoepithelial Cell Markers in the Differential Diagnosis of Benign, In situ, and Invasive Lesions of the Breast.

Corben AD, Lerwill MF.

Surg Pathol Clin. 2009 Jun;2(2):351-73. doi: 10.1016/j.path.2009.02.003. Epub 2009 Jun 2. Review.

PMID:
26838326
10.

Role of myoepithelial cells in breast tumor progression.

Pandey PR, Saidou J, Watabe K.

Front Biosci (Landmark Ed). 2010 Jan 1;15:226-36. Review.

11.

Calponin expression in laryngeal myoepithelial carcinoma and its prognostic implications: a case report and literature review.

Mao YJ, Luo XM, Zhou SH, Zheng ZJ.

J Int Med Res. 2010 Mar-Apr;38(2):711-9. Review. Erratum in: J Int Med Res. 2011;39(4):1570-1.

PMID:
20515587
12.

Invasion in breast lesions: the role of the epithelial-stroma barrier.

Rakha EA, Miligy I, Gorringe KL, Toss MS, Green AR, Fox SB, Schmitt FC, Tan PH, Tse GM, Badve S, Decker T, Vincent-Salomon A, Dabbs DJ, Foschini MP, Moreno F, Wentao Y, Geyer FC, Reis-Filho JS, Pinder SE, Lakhani SR, Ellis IO.

Histopathology. 2017 Dec 2. doi: 10.1111/his.13446. [Epub ahead of print] Review.

PMID:
29197112
13.

Papillary carcinoma of the breast: an overview.

Pal SK, Lau SK, Kruper L, Nwoye U, Garberoglio C, Gupta RK, Paz B, Vora L, Guzman E, Artinyan A, Somlo G.

Breast Cancer Res Treat. 2010 Aug;122(3):637-45. doi: 10.1007/s10549-010-0961-5. Epub 2010 Jun 4. Review.

14.

Immunohistochemistry in the diagnostic evaluation of breast lesions.

Hicks DG.

Appl Immunohistochem Mol Morphol. 2011 Dec;19(6):501-5. doi: 10.1097/PAI.0b013e31822c8a48. Review.

PMID:
22089489

Supplemental Content

Support Center